Literature DB >> 9715251

Soluble receptors in human disease.

M L Heaney1, D W Golde.   

Abstract

Soluble cytokine receptors naturally arise from genes encoding membrane-bound receptors or are direct derivatives of the receptors themselves. There is mounting evidence that soluble receptors play important roles in human disease states. In many cases, soluble receptors appear to play an integral part in the dynamic interaction between ligands and their membrane-bound receptors in maintaining and restoring health after a pathological insult but, in some instances, dysregulated expression of soluble receptors can contribute to disease pathology. Nonetheless, an appreciation of the biological actions of soluble receptors, particularly as cytokine inhibitors, has led to their therapeutic use in human diseases. Although early clinical trails of soluble receptors have had unexpected toxicities, their application in medicine continues to advance and it is likely that soluble receptors will join hormones, cytokines, and growth factors as established biological therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715251     DOI: 10.1002/jlb.64.2.135

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  48 in total

1.  Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.

Authors:  P Li; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Measurement of tumour necrosis factor receptors for immune response in colon cancer patients.

Authors:  K Venetsanou; V Kaldis; N Kouzanidis; Ch Papazacharias; J Paraskevopoulos; G Baltopoulos
Journal:  Clin Exp Med       Date:  2011-11-01       Impact factor: 3.984

3.  Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.

Authors:  T Shigenaga; A M Dannenberg; D B Lowrie; W Said; M J Urist; H Abbey; B H Schofield; P Mounts; K Sugisaki
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

4.  Factors associated with inflammation markers, a cross-sectional analysis.

Authors:  Tess V Clendenen; Karen L Koenig; Alan A Arslan; Annekatrin Lukanova; Franco Berrino; Yian Gu; Goran Hallmans; Annika Idahl; Vittorio Krogh; Anna E Lokshin; Eva Lundin; Paola Muti; Adele Marrangoni; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

5.  Altered folate binding protein expression and folate delivery are associated with congenital hydrocephalus in the hydrocephalic Texas rat.

Authors:  Alicia Requena Jimenez; Naila Naz; Jaleel A Miyan
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-25       Impact factor: 6.200

6.  Clinical outcomes in patients with ICU-related pancreatitis.

Authors:  Chia-Cheng Tseng; Wen-Feng Fang; Yu-Hsiu Chung; Yi-Hsi Wang; Ivor S Douglas; Meng-Chih Lin
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

7.  Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.

Authors:  Timothy J Franxman; Laura E Howe; James R Baker
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

8.  Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role.

Authors:  Jianping Huang; Caroline Jochems; Tara Talaie; Austin Anderson; Alessandra Jales; Kwong Y Tsang; Ravi A Madan; James L Gulley; Jeffrey Schlom
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

9.  Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters.

Authors:  T H Tu; C-S Kim; J-H Kang; I S Nam-Goong; C W Nam; E S Kim; Y I Kim; J I Choi; T Kawada; T Goto; T Park; J H Yoon Park; M-S Choi; R Yu
Journal:  Int J Obes (Lond)       Date:  2013-11-27       Impact factor: 5.095

10.  Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.

Authors:  Jianping Huang; Caroline Jochems; Austin M Anderson; Tara Talaie; Alessandra Jales; Ravi A Madan; James W Hodge; Kwong Y Tsang; David J Liewehr; Seth M Steinberg; James L Gulley; Jeffrey Schlom
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.